全文获取类型
收费全文 | 40145篇 |
免费 | 1936篇 |
国内免费 | 211篇 |
专业分类
耳鼻咽喉 | 486篇 |
儿科学 | 824篇 |
妇产科学 | 633篇 |
基础医学 | 5502篇 |
口腔科学 | 1312篇 |
临床医学 | 2989篇 |
内科学 | 9945篇 |
皮肤病学 | 971篇 |
神经病学 | 3056篇 |
特种医学 | 1481篇 |
外科学 | 6296篇 |
综合类 | 233篇 |
一般理论 | 2篇 |
预防医学 | 1205篇 |
眼科学 | 589篇 |
药学 | 2842篇 |
中国医学 | 89篇 |
肿瘤学 | 3837篇 |
出版年
2022年 | 282篇 |
2021年 | 726篇 |
2020年 | 326篇 |
2019年 | 514篇 |
2018年 | 704篇 |
2017年 | 508篇 |
2016年 | 594篇 |
2015年 | 685篇 |
2014年 | 908篇 |
2013年 | 1051篇 |
2012年 | 1699篇 |
2011年 | 1825篇 |
2010年 | 1018篇 |
2009年 | 947篇 |
2008年 | 1727篇 |
2007年 | 1875篇 |
2006年 | 1864篇 |
2005年 | 1944篇 |
2004年 | 1921篇 |
2003年 | 1868篇 |
2002年 | 1912篇 |
2001年 | 1308篇 |
2000年 | 1428篇 |
1999年 | 1324篇 |
1998年 | 550篇 |
1997年 | 401篇 |
1996年 | 433篇 |
1995年 | 397篇 |
1994年 | 376篇 |
1993年 | 364篇 |
1992年 | 886篇 |
1991年 | 833篇 |
1990年 | 749篇 |
1989年 | 772篇 |
1988年 | 720篇 |
1987年 | 704篇 |
1986年 | 706篇 |
1985年 | 632篇 |
1984年 | 474篇 |
1983年 | 389篇 |
1982年 | 227篇 |
1979年 | 368篇 |
1978年 | 256篇 |
1977年 | 216篇 |
1975年 | 218篇 |
1974年 | 240篇 |
1973年 | 221篇 |
1971年 | 216篇 |
1970年 | 214篇 |
1969年 | 232篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Toshihiro Yoshitake Akira Takeda Kensaku Ohki Yuko Inoue Takanori Yamawaki Saori Otsuka Minekatsu Akimoto Mitsuru Nemoto Yasuhito Shimakura Akio Sato 《The Journal of dermatology》2015,42(7):735-738
Finasteride is standard medical treatment for androgenetic alopecia; however, no large studies with 5 years or more of follow up have been performed in Japan. The authors followed Japanese men with androgenetic alopecia treated with finasteride for 5 years to evaluate long‐term treatment efficacy. Of 903 men treated with finasteride (1 mg/day), 801 patients were evaluated over 5 years by modified global photographic assessment. Although the proportion of improvement was high (99.4%), modified global photographic assessment scores after 5 years of treatment were lower in patients with more advanced disease as measured by the modified Norwood–Hamilton scale. After separating patients into “sufficient” and “insufficient” efficacy groups according to the modified global photographic assessment score after 5 years (scores ≥6 and <6, respectively), multivariate analysis showed that independent risk factors of insufficient efficacy were age at start of treatment of 40 years or more (P = 0.021) and classification on the modified Norwood–Hamilton scale (P < 0.001), whereas presence of stress at start of treatment was a negative predictor (P = 0.025). In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. Younger age and less advanced disease at start of treatment were the key predictors of higher finasteride efficacy. 相似文献
3.
4.
5.
6.
Marcelo Sato‐Sano Solange Pistori Teixeira Juliano Cordova Vargas Otvio Cesar Carvalho Guimares Baiocchi Milvia Maria Simes e Silva Enokihara Elimar Elias Gomes Mariana Dias Batista 《The Journal of dermatology》2019,46(7):618-621
Eosinophilic dermatosis of hematological malignancy is a paraneoplastic skin eruption associated with chronic lymphocytic leukemia and other B‐cell malignancies. It clinically resembles an insect bite reaction and it can precede the symptoms of the hematological malignancy or be related to a more aggressive course. Different treatments have been proposed, but partial response and recurrence are frequent. Herein, we describe a case of eosinophilic dermatosis associated with mantle cell lymphoma with remission after lenalidomide therapy. 相似文献
7.
8.
9.
Takao Itoi Atsushi Sofuni Fumihide Itokawa Yasushi Shinohara Kazuya Takeda Kazuto Nakamura Toshio Kurihara Takayoshi Tsuchiya Fuminori Moriyasu 《Digestive endoscopy》2006,18(3):232-238
We describe our methods and outcomes of multidisciplinary treatments in patients with unresectable hilar cholangiocarcinoma. Fifty‐seven patients with a known outcome were enrolled. Thirty‐four of 57 patients were treated and evaluated by salvage therapy. For salvage therapy, we used internal and external radiotherapy, photodynamic therapy, YAG laser therapy and microwave coagulation therapy. The median survival time was 548 days for the group receiving salvage therapy and 198 days for the group not receiving this treatment. In conclusion, although no randomization of the patients was performed in this retrospective study, our present data provide convincing evidence that salvage therapy is a useful therapeutic approach for unresectable hilar cholangiocarcinomas. 相似文献
10.
Toshio Kushiro Hiroshige Itakura Yoshihisa Abo Hiromi Gotou Shinji Terao Deborah L Keefe 《Hypertension research》2006,29(12):997-1005
Aliskiren is a novel orally active renin inhibitor for the treatment of hypertension. This study evaluated the antihypertensive efficacy, safety and tolerability of aliskiren in Japanese patients with hypertension. Forty hundred and fifty-five Japanese men and women with a mean sitting diastolic blood pressure of 95-110 mmHg were randomized to receive once-daily double-blind treatment for 8 weeks with aliskiren 75, 150 or 300 mg or placebo. Aliskiren produced significant, dose-dependent reductions in mean sitting diastolic blood pressure (p<0.0005 vs. placebo for each dose) and mean sitting systolic blood pressure (p<0.001 vs. placebo for each dose). The placebo-corrected reductions in mean sitting systolic/diastolic blood pressure were 5.7/4.0, 5.9/4.5 and 11.2/7.5 mmHg in the aliskiren 75, 150 and 300 mg groups, respectively. After 8 weeks' treatment, 27.8%, 47.8%, 48.2% and 63.7% of patients in the placebo and aliskiren 75, 150 and 300 mg groups, respectively, achieved a successful treatment response (diastolic blood pressure <90 mmHg and/or reduced by > or =10 mmHg from baseline; p<0.005 vs. placebo for each dose). Aliskiren treatment was well tolerated, with the incidence of adverse events reported in the active treatment groups (53-55%) being similar to that in the placebo group (50%). This study, which is the first to assess the antihypertensive efficacy and safety of aliskiren in Japanese patients with hypertension, demonstrates that the once-daily oral renin inhibitor aliskiren provides significant, dose-dependent reductions in blood pressure with placebo-like tolerability. 相似文献